Morepen Laboratories reports 51% jump in export sales revenue in Q4FY19

Morepen Laboratories Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500288 | NSE: MOREPENLAB

06 May 2019 Evaluate

Morepen Laboratories has reported export sales revenue up by 51% at Rs 96.41 crore due to high impetus in API business for Q4FY19. The company’s domestic sales revenue up by 13% at Rs 118.84 crore.

Besides, the company’s API sales revenue grew by 34% at Rs 125.48 crore and Home Diagnostics Sales Revenue by 12% at Rs 27.77 crore in Q4FY19 and formulation sales revenue jumped by 30% at Rs 49.35 crore.

Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.50
Dr. Reddys Labs.	1202.80
Cipla	1397.20
Lupin	2090.00
Zydus Lifesciences	1202.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.